Partnership extends PRA bioanalytical services in North America 2 December 2008, Raleigh, N.C. — PRA International, a leading Clinical Research Organization (CRO), announced today a collaborative agreement with Frontage Laboratories Inc. This partnership enables PRA Early Development Services’ US Clinical Pharmacology Center (PRA EDS US CPC) to now offer a full complement of analytical lab testing services to its existing Phase I – IV clinical trial services in North America.  PRA’s state-of-the-art, 80-bed Lenexa clinical…

Partnership extends PRA bioanalytical services in North America 2 December 2008, Raleigh, N.C. — PRA International, a leading Clinical Research Organization (CRO), announced today a collaborative agreement with Frontage Laboratories Inc. This partnership enables PRA Early Development Services’ US Clinical Pharmacology Center (PRA EDS US CPC) to now offer a full complement of analytical lab testing services to its existing Phase I – IV clinical trial services in North America.  PRA’s state-of-the-art, 80-bed Lenexa clinical…

ETS Laboratories announces the exclusive licensing of DxS Scorpions™ technology to test for contaminant microorganisms that reduce yields in biofuel fermentations. Process optimization and targeted control of contaminant microbes can increase profitability. Read »

Regenerative Medicine Company Poised for Business Growth Read »

Despite roller-coaster changes in the U.S. and worldwide stock markets, the trend in health care employment could be counted on once again: tens of thousands of new jobs created in October, bringing yearly growth up over 345,000.The MedZilla.com Employment Report analyzes the numbers for October 2008 and announces the findings. Read »

DuPont Applied BioSciences has turned to MBI International to join the DuPont team in evaluating the commercial viability of an important bio-based product line. MBI International is a leader in bridging the gap between research and commercialization through collaborative de-risking of bio-based technologies. MBI’s unique “Collaborative De-Risking” process systematically addresses technological uncertainties, which impede new technologies from getting to market. Read »

Consumers cutting "experimental luxuries" such as expensive spa and anti-aging treatments seek out comparable alternatives at more affordable prices. Instead of hiring someone else to pamper them, they pamper themselves by re-creating that same relaxing atmosphere and experience at home. ZhēnSpa, a new spa facial line, meets this growing demand for high quality treatments outside of the day spa. Read »

Major biopharmaceutical companies with substantial internal mammalian cell culture capability are forecast to have adequate internal manufacturing capacity. Contract mammalian cell culture manufacturers (CMOs) however, are likely to feel the pressure of increased utilization rates. For these CMOs and biopharmaceutical companies depending on them, understanding critical demand drivers, market factors and manufacturing trends is instrumental to making effective strategic supply decisions. Read »

Alvaro Fernandez, CEO of market research firm SharpBrains, will lead a webinar discussing the Top 10 Cognitive Fitness Events of 2008 with leading healthcare and insurance providers. Read »

Avreo interWORKS interVIEW receives the highest performance score among a growing list of solutions from both large enterprise firms and small low-cost vendors Read »